Enzymes Present In The Sperm
🛑 ALL INFORMATION CLICK HERE 👈🏻👈🏻👈🏻
Enzymes Present In The Sperm
Your source for the latest research news
make a difference: sponsored opportunity
NIH/National Institute Of Child Health And Human Development Of The National Institutes Of Health. "Enzyme Essential To Sperm Movement Provides Target For New Contraceptive Approach." ScienceDaily. ScienceDaily, 19 November 2004. .
NIH/National Institute Of Child Health And Human Development Of The National Institutes Of Health. (2004, November 19). Enzyme Essential To Sperm Movement Provides Target For New Contraceptive Approach. ScienceDaily . Retrieved September 7, 2022 from www.sciencedaily.com/releases/2004/11/041118113107.htm
NIH/National Institute Of Child Health And Human Development Of The National Institutes Of Health. "Enzyme Essential To Sperm Movement Provides Target For New Contraceptive Approach." ScienceDaily. www.sciencedaily.com/releases/2004/11/041118113107.htm (accessed September 7, 2022).
RELATED TOPICS
Health & Medicine
Fertility
Pregnancy and Childbirth
Prostate Cancer
Men's Health
Stem Cells
Birth Control
Pharmacology
Sexual Health
RELATED TERMS
Somatic cell
Mammalian embryogenesis
Somatic cell nuclear transfer
Embryo
In vitro fertilization
Artificial insemination
Spermatozoon
Semen
Mar. 31, 2022 — Out of about 100 million sperm, only a few hundred make it to the fallopian tubes. A directional movement called rheotaxis, guides sperm cells to swim against the cervical mucus flow to reach the egg ...
Feb. 4, 2021 — Competition among sperm cells is fierce - they all want to reach the egg cell first to fertilize it. A research team now shows in mice that the ability of sperm to move progressively depends on the ...
Dec. 2, 2019 — Researchers have characterized a protein, called VSP, that keeps sperm swimming in straight lines. Deletion of the protein caused sperm to swim in circles, significantly reducing fertilization rates. ...
July 18, 2019 — Why does it take 200 million sperm to fertilize a single egg? Part of the reason is bombardment by the female immune system, which very few sperm survive. Researchers have discovered a molecular ...
Toggle navigation
Menu
S D
S D
Home Page
Top Science News
Latest News
View all the latest top news in the health sciences, or browse the topics below:
View all the latest top news in the physical sciences & technology, or browse the topics below:
View all the latest top news in the environmental sciences, or browse the topics below:
View all the latest top news in the social sciences & education, or browse the topics below:
Copyright 1995-2022 ScienceDaily or by other parties, where indicated. All rights controlled by their respective owners.
Content on this website is for information only. It is not intended to provide medical or other professional advice.
Views expressed here do not necessarily reflect those of ScienceDaily, its staff, its contributors, or its partners.
Financial support for ScienceDaily comes from advertisements and referral programs, where indicated.
Enzyme Essential To Sperm Movement Provides Target For New Contraceptive Approach https://www.sciencedaily.com/releases/2004/11/041118113107.htm
A team of researchers has determined that an enzyme in sperm is necessary for sperm movement. Mice bred to lack this enzyme produce sperm that cannot swim toward egg cells to fertilize them.
A team of researchers has determined that an enzyme in sperm is necessary for sperm movement. Mice bred to lack this enzyme produce sperm that cannot swim toward egg cells to fertilize them.
The enzyme, known as GAPDS, is essentially the same as an enzyme produced in human sperm. The researchers believe that designing a drug to disable the enzyme might provide the basis for an effective new form of male contraception. Similarly, an understanding of the enzyme and related chemical reactions might lead to insights into treatment for some forms of male infertility.
"Currently, attempts to design a male contraceptive involve manipulating male hormones," said Duane Alexander, M.D., Director of the NICHD. "This finding provides a promising new lead that might allow development of a contraceptive that targets only sperm and doesn't affect natural hormone levels."
Enzymes are chemical compounds that assist a chemical reaction.
The study was funded by the National Institute of Child Health and Human Development of the National Institutes of Health, and will appear in the Proceedings of the National Academy of Sciences Online Early Edition the week of November 15, 2004.
GAPDS, short for Glyceraldehyde 3-phosphate dehydrogenase-S, is a key enzyme in a series of biochemical reactions known as glycolysis. This series of reactions produces ATP, a kind of cellular fuel that supplies energy for the cell's activities. GAPDS is found only in sperm (the final "S" in the acronym stands for sperm) and the precursor cells that give rise to sperm. However, a related enzyme is present in virtually all the cells in the body.
GAPDS is found in the sperm's flagellum, the snake-like tail which whips back and forth to propel the sperm forward. In earlier studies, researchers found that glycolysis played a role in sperm movement, but did not know how much of the total amount of ATP in sperm resulted from glycolysis. Before the current study, most researchers believed that most of the ATP for the tail's movement came largely from cellular bodies called mitochondria, which are thought to generate more ATP than does glycolysis.
In the current study, Dr. Deborah O'Brien, Ph.D., of the University of North Carolina School of Medicine at Chapel Hill and her colleagues sought to determine if sperm require GAPDS and glycolysis in order to move forward and fertilize eggs. Using molecular genetic techniques, they generated a strain of mice that were genetically incapable of producing GAPDS. Although the mice mated normally with receptive female mice, the females did not become pregnant. When the researchers examined sperm from the mice under a microscope, the sperm showed only a slight side-to-side movement, but were incapable of moving forward.
"We were very surprised at this finding," Dr. O'Brien said. "It turned out that almost all of the sperm's motility and ATP production depended on this enzyme."
At this point, the researchers know that sperm lacking GAPDS can not swim forward toward the egg, but they did not conduct studies to determine whether the GAPDS-deficient sperm could fertilize eggs with which they are placed in contact.
Dr. O'Brien's study was funded as part of NICHD's Specialized Cooperative Centers Program in Reproduction Research, which seeks to identify compounds that might provide the basis for new forms of contraception and provide insights that might be helpful in treating infertility.
The human form of GAPDS is known as GAPD2, explained Louis De Paolo, Ph.D., of NICHD's Reproductive Sciences Branch, administrator of the Specialized Centers Program. A drug that interfered with the enzyme might provide an effective means of nonhormonal male contraception.
One possibility, he added, would be a drug that males could take to interfere with sperm motility. Another possibility would be a drug that could be deposited in the female reproductive tract, which could stop the movement of sperm when they come in contact with it.
Dr. De Paolo noted that current attempts to design a male contraceptive pill involve drugs that temporarily halt the functioning of the testes. These drugs not only suppress sperm production, but also the production of the male hormone testosterone, necessary for normal reproductive functioning. Such treatments typically involve replacing the missing testosterone through artificial means — a process that could increase the risk for prostate cancer. A drug that interfered with GAPD2 would leave testosterone levels unaffected, he said.
Similarly, studying the functioning of GAPD2 might provide insights that could lead to treatments for male infertility.
"One study showed that in a sample of infertile men, about 81 percent had sperm with defects in motility," Dr. De Paolo said.
Some of these men might have a genetic defect that interferes with normal production of GAPD2, he added. A drug that restored GAPD2 functioning might provide a treatment for their infertility. Similar molecular defects in the glycolysis pathway that produces ATP might also interfere with sperm movement, and might be the focus of other treatments.
"This finding has opened up several exciting new possibilities for future studies of male fertility regulation," he said.
The NICHD is part of the National Institutes of Health (NIH), the biomedical research arm of the federal government. NIH is an agency of the U.S. Department of Health and Human Services. The NICHD sponsors research on development, before and after birth; maternal, child, and family health; reproductive biology and population issues; and medical rehabilitation. NICHD publications, as well as information about the Institute, are available from the NICHD Web site, http://www.nichd.nih.gov , or from the NICHD Information Resource Center, 1-800-370-2943; e-mail NICHDInformationResourceCenter@mail.nih.gov .
Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:
Keep up to date with the latest news from ScienceDaily via social networks:
Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Clipboard, Search History, and several other advanced features are temporarily unavailable.
Dashboard
Publications
Account settings
Log out
Advanced
Clipboard
Format
Abstract
PubMed
PMID
Format:
Summary (text)
PubMed
PMID
Abstract (text)
CSV
Subject:
1 selected item: 6409171 - PubMed
Format:
Summary
Summary (text)
Abstract
Abstract (text)
Create a new collection
Add to an existing collection
Name must be less than 100 characters
Unable to load your collection due to an error
Please try again
Unable to load your delegates due to an error
Please try again
Would you like email updates of new search results?
Saved Search Alert Radio Buttons
Yes
No
Frequency:
Monthly
Weekly
Daily
Which day?
The first Sunday
The first Monday
The first Tuesday
The first Wednesday
The first Thursday
The first Friday
The first Saturday
The first day
The first weekday
Which day?
Sunday
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Report format:
Summary
Summary (text)
Abstract
Abstract (text)
PubMed
Send at most:
1 item
5 items
10 items
20 items
50 items
100 items
200 items
Send even when there aren't any new results
Number of items displayed:
5
10
15
20
50
100
Page navigation
Title & authors
Abstract
Similar articles
Cited by
Publication types
MeSH terms
Substances
Related information
Grant support
LinkOut - more resources
S Mack et al.
Biol Reprod .
1983 Jun .
Format
Abstract
PubMed
PMID
Sillerico T, Valdivia M, de Ioannes A, Barros C.
Sillerico T, et al.
Biocell. 1996 Aug;20(2):133-42.
Biocell. 1996.
PMID: 8916460
Nuzzo NA, Anderson RA Jr, Zaneveld LJ.
Nuzzo NA, et al.
Mol Reprod Dev. 1990 Jan;25(1):52-60. doi: 10.1002/mrd.1080250110.
Mol Reprod Dev. 1990.
PMID: 2118365
NagDas SK, Winfrey VP, Olson GE.
NagDas SK, et al.
Biol Reprod. 1996 Dec;55(6):1405-14. doi: 10.1095/biolreprod55.6.1405.
Biol Reprod. 1996.
PMID: 8949900
Morton DB.
Morton DB.
Front Biol. 1976;45:203-55.
Front Biol. 1976.
PMID: 185098
Review.
No abstract available.
Barros C, Crosby JA, Moreno RD.
Barros C, et al.
Cell Biol Int. 1996 Jan;20(1):33-9. doi: 10.1006/cbir.1996.0006.
Cell Biol Int. 1996.
PMID: 8936405
Review.
Yokoe M, Sano M, Shibata H, Shibata D, Takayama-Watanabe E, Inaba K, Watanabe A.
Yokoe M, et al.
Int J Mol Sci. 2014 Aug 28;15(9):15210-24. doi: 10.3390/ijms150915210.
Int J Mol Sci. 2014.
PMID: 25170808
Free PMC article.
Gergely A, Szöllösi J, Falkai G, Resch B, Kovacs L, Huszar G.
Gergely A, et al.
J Assist Reprod Genet. 1999 Jan;16(1):35-40. doi: 10.1023/a:1022545612784.
J Assist Reprod Genet. 1999.
PMID: 9987692
Free PMC article.
Schill WB.
Schill WB.
Arch Dermatol Res. 1990;282(5):335-42. doi: 10.1007/BF00375729.
Arch Dermatol Res. 1990.
PMID: 2121108
Format:
AMA
APA
MLA
NLM
Send To
Clipboard
Email
Save
My Bibliography
Collections
Citation Manager
[x]
NLM
NIH
HHS
USA.gov
An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
The effect of in vitro capacitation (events that occur before the acrosome reaction) on the acrosomal enzymes of human spermatozoa was determined. Capacitation of human spermatozoa was assessed by their ability to penetrate denuded hamster oocytes. The activities of a number of enzymes commonly associated with the sperm acrosome, including nonzymogen acrosin, proacrosin, inhibitor-bound acrosin, hyaluronidase, acid phosphatase, beta-glucuronidase, beta-glucosidase, beta-N-acetylglucosaminidase, beta-galactosidase and beta-N-acetylgalactosaminidase were assessed. With the exception of acid phosphatase, no alteration in enzyme activity occurred after 4 h of incubating the spermatozoa under capacitation conditions although gamete fusion took place. The acid phosphatase levels decreased twofold, presumably due to the loss of seminal (prostatic acid phosphatase that loosely adheres to spermatozoa. After 8 h of capacitation, a large decrease in sperm enzyme levels took place only in the case of hyaluronidase, although small decreases were also noted in total acrosin, proacrosin and inhibited acrosin. No new electrophoretically migrating forms of acrosin were observed. Decreases in total acrosin and proacrosin, but not in inhibited acrosin, also occurred when spermatozoa were incubated under noncapacitating conditions for 8 h, indicating that capacitation may specifically cause the release of some acrosin inhibitor from human spermatozoa. It is concluded that, with the possible exception of hyaluronidase, the in vitro capacitation of human spermatozoa does not cause a major change in its acrosomal enzyme content so that these hydrolases are fully present before the acrosome reaction takes place during gamete fusion. Serum albumin appears to protect against the loss of some of these enzymes since the activity of several glycosidases was significantly reduced when the spermatozoa were incubated for 8 h in human serum albumin-free medium.
MeSH
PMC
Bookshelf
Disclaimer
Help
Accessibility
Careers
Ask and Answer Questions
Earn Poi
Girl Sperm
Nasty Green
Sex Video Little Oral Andie